FOREWARN, a safety solutions provider for real estate professionals, introduced Community Alerts, a new feature that allows agents to flag phone numbers after concerning interactions. This alert is instantly shared across its network of over 443,000 users, helping agents receive warnings before engaging with potentially risky contacts. The system enhances safety by leveraging shared experiences, providing real-time caution signals beyond traditional identity checks. This feature is free for all FOREWARN customers and aims to improve agent safety nationwide.
FOREWARN's new Community Alerts feature is introduced as a safety tool for real estate agents. For readers following real estate, here is Pluang's market snapshot as of Oct 26, 2026 18:32 WIB: Of 47 priced US real estate stocks, 19 rose and 5 fell. Notable movers include WELL at USD 238.67 (+0.57%), PLD at USD 127.10 (+0.51%), and EPR at USD 56.20 (+0.41%).
Senseonics Holdings has begun the first human clinical trial of Freedom, a next-generation continuous glucose monitoring (CGM) system designed without an external on-body transmitter. This implantable device communicates directly with mobile devices ...
Stryker Corporation has finalized its acquisition of ZuriMED, incorporating the FiberLocker System into its Sports Medicine offerings. This technology enhances rotator cuff repair by improving biomechanical strength, addressing a key clinical need. T...
Kratos Defense & Security Solutions announced it will release its third quarter 2026 financial results after market close on November 5, 2026. The company will hold a conference call at 2:00 p.m. Pacific Time to discuss its operations and financial p...
Franklin Electric Co., Inc. announced a quarterly cash dividend of $0.28 per share, payable on November 19, 2026, to shareholders of record as of November 5, 2026. This dividend reflects the company's ongoing commitment to returning value to its shar...
Eikon Therapeutics presented updated data on EIK1001, a TLR7/8 dual-agonist, combined with pembrolizumab and chemotherapy for stage 4 non-small cell lung cancer (NSCLC) at the 2026 ESMO Congress. The treatment showed a 72% objective response rate and...
